Current role
Douglas E. Williams, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Douglas E. Williams, Ph.D.
Sana Biotechnology, Inc. reported in an 8-K filed April 10, 2023 that Douglas E. Williams, Ph.D. was appointed Executive Vice President and President, Research and Development, effective April 10, 2023.
“On April 10, 2023, Sana Biotechnology, Inc. (the "Company") announced that Douglas E. Williams, Ph.D., has been appointed and will join the Company as Executive Vice President and President, Research and Development, effective April 10, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sana Biotechnology, Inc. (SANA)
SEC 8-K
Current2023-04-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sana Biotechnology, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Piper CFO
- Steven D. Harr CFO
- Steven D. Harr, M.D. CFO, Board Member
- Susan Wyrick CFO
- Aaron M. Grossman General Counsel
- Alise S. Reicin Board Member
- Hans E. Bishop Board Member
- Robert Nelsen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.